Filing Flows

Filing Flows › Charles River Laboratories International (CRL) › Q3 2026

Charles River Laboratories International (CRL) Q3 2026 earnings results (third quarter 2026)

10-Q filed Nov 4, 2026

Charles River Laboratories International (CRL) reported revenue of $983M for the third quarter 2026 (Q3 2026), -2% from a year earlier and -2% from the quarter before. Operating margin was 20.6%, net earnings $333M (33.9% of revenue).

Revenue$983M
Year over year-2%
Quarter over quarter-2%
Operating margin20.6%
Net earnings$333M

Charles River Laboratories International, Q3 2026: revenue $983M (-2% year over year), operating margin 20.6%, net earnings $333M, operating cash flow $254M. The chart follows the revenue to costs, profit and cash.

Q3 2026AmountQ/QY/Y
Revenue$983M-2%-2%
Operating profit$203M+69%+51%
Net earnings$333M—+512%
Operating cash flow$254M+41%+19%
Free cash flow$207M+39%+16%

What changed

Revenue was $982.7M in Q3 2026, down 2% year over year and down 2% from the previous quarter. DSA was the largest line at 61% of revenue. Manufacturing lost $11.8M year over year (down 6%), 53% of the total change.

Operating profit was $202.6M, a 20.6% margin (up 7.3 points year over year). Total costs fell 10% while revenue fell 2%. Net earnings were $333.1M, up 512% year over year. The effective tax rate was -96.0%.

Operating cash flow was $254.1M (up 19% year over year), 76% of net earnings. Non-cash charges added back $72.3M of depreciation and amortization and $20.8M of share-based compensation. Working capital and other items used $173.4M. Capital expenditures of $46.8M left free cash flow of $207.3M.

Questions

What was Charles River Laboratories International's revenue in the third quarter 2026?

Charles River Laboratories International (CRL) reported revenue of $983M for the third quarter 2026 (Q3 2026), -2% from a year earlier and -2% from the quarter before.

Was Charles River Laboratories International profitable in the third quarter 2026?

Operating profit was $203M (20.6% of revenue) and net earnings $333M.

Open the interactive Sankey →

Source: Charles River Laboratories International 10-Q on SEC EDGAR.